While building a simpler model for particle interactions, scientists made a sleek new pi. Representations of pi help scientists use values close to real life without storing a million digits. The ...

The U.S. Federal Aviation Administration (FAA) has cleared Firefly Aerospace to resume launches of its Alpha rocket. The approval follows a months-long review of the failed "Message in a Booster" ...

Doug Clinton, Intelligent Alpha founder and CEO, joins 'Closing Bell' to discuss the excitement around equities, if investors have to take a leap of faith on AI companies and much more. Questions ...

Prince George’s County officials had raised some concerns about a charter school’s stability months before it abruptly closed in August, records show. School district officials sent a letter in the ...

From reproductive rights to climate change to Big Tech, The Independent is on the ground when the story is developing. Whether it's investigating the financials of Elon Musk's pro-Trump PAC or ...

After President Donald Trump killed off electric vehicle tax credits in January, many assumed the death of the $5 billion EV charging station program would soon follow. Indeed, Transportation ...

Sir Christopher Pissarides was awarded a Nobel Prize in 2010 for his work on economic "frictions," or market inefficiencies. These days, he's focused more on new mental frictions rather than market ...

Nvidia (NASDAQ:NVDA) spent more than $900M to hire Enfabrica CEO Rochan Sankar and other employees and to license the AI hardware startup's technology, CNBC reported. Nvidia is paying cash and stock ...

The Federal Reserve Bank of Boston had an interesting piece last month about the resilience of consumer spending, which is ~70% of GDP in the US. They looked at credit card spending data for low, ...

Drivers, start your engines! The 2025 Formula One United States Grand Prix is nearly upon us, a time when hundreds of thousands of motorsport fans flock to Central Texas to get an up-close look at the ...

Moderna (MRNA) announced “positive” preliminary immunogenicity data for the 2025-2026 formula of Spikevax, which targets the LP.8.1 variant of SARS-CoV-2 to help prevent COVID-19. “The data from an ...